The potential impact of human visceral leishmaniasis vaccines on population incidence

Epke A le Rutte, Luc E Coffeng, Stefano Malvolti, Paul M. Kaye, Sake J de Vlas
doi: https://doi.org/10.1101/2020.05.05.20090480

Article Information

doi 
https://doi.org/10.1101/2020.05.05.20090480
History 
  • May 8, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Epke A le Rutte1,2,3,*,
  2. Luc E Coffeng1,
  3. Stefano Malvolti4,
  4. Paul M. Kaye5 and
  5. Sake J de Vlas1
  1. 1Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands,
  2. 2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland,
  3. 3University of Basel, Basel, Switzerland,
  4. 4MM Global Health Consulting, Zurich, Switzerland,
  5. 5York Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom
  1. ↵*Corresponding author: e.lerutte{at}erasmusmc.nl
Back to top
Posted May 08, 2020.
Download PDF
Data/Code
Email
The potential impact of human visceral leishmaniasis vaccines on population incidence
Epke A le Rutte, Luc E Coffeng, Stefano Malvolti, Paul M. Kaye, Sake J de Vlas
medRxiv 2020.05.05.20090480; doi: https://doi.org/10.1101/2020.05.05.20090480
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area